ENSr Medical, Inc. believes that the future of safe, effective and cost efficient treatment of pain is a patient centered approach. The Company produces the FIRSTtx device, an FDA cleared medical device that can be prescribed to manage or eliminate pain. In most cases, a non-pharmacological approach is in an individual patient’s best interest and we believe that our approach is superior to any existing drug-free pain solution. Welcome to 21st Century neural medicine.

It is estimated that:

  • More people died from drug overdoses in 2015 than in any year on record. The majority of drug overdose deaths involve an opioid. Since 1999, the number of overdose deaths involving opioids (including prescription opioid pain relievers and heroin) nearly quadrupled. From 2000 to 2014 nearly half a million people died from drug overdoses. 78 Americans die every day from an opioid overdose. We now know that overdoses from prescription opioid pain relievers are a driving factor in the 15-year increase in opioid overdose deaths. Since 1999, the amount of prescription opioids sold in the U.S. nearly quadrupled, yet there has not been an overall change in the amount of pain that Americans report. Deaths from prescription opioids—drugs like oxycodone, hydrocodone, and methadone — have also quadrupledsince 1999.”  [1]
  • $3.5 billion is spent on extra medical costs of ADRs annually [2]
  • Back pain is an epidemic. 31 million Americans are suffering back pain. Back pain in workers 40-65 years of age costs employers an estimated $7.4 Billion per year. Back pain is the second leading cause of missed work, lagging only behind the common cold and upper respiratory illnesses! [3]
  • “The prevalence of age-related diseases and chronic neurological disorders is increasing globally.  [4]

1.  CDC – Understanding the Epidemic, 2016; www.cdc.gov/mmwr/preview/mmwrhtml/mm6450a3.htm?s_cid=mm6450a3_w

2. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006;296:1858-66.

4. American Academy of Orthopaedic Surgeons (AAOS), 2004.

5. Visiongain, Neuromodulaton Devices Report 2016- 2026.